Show simple item record

dc.contributor.authorTabatabaei Mirakabad, FS
dc.contributor.authorAkbarzadeh, A
dc.contributor.authorMilani, M
dc.contributor.authorZarghami, N
dc.contributor.authorTaheri-Anganeh, M
dc.contributor.authorZeighamian, V
dc.contributor.authorBadrzadeh, F
dc.contributor.authorRahmati-Yamchi, M
dc.date.accessioned2018-08-26T06:04:24Z
dc.date.available2018-08-26T06:04:24Z
dc.date.issued2016
dc.identifier10.3109/21691401.2014.955108
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/41433
dc.description.abstractBreast cancer is the most commonly diagnosed cancer and the leading cause of cancer death among women worldwide. Herbal medicines have tremendous potential as promising agents for the treatment of cancer. Curcumin is a natural polyphenol which has many anticancer effects. Because of its low aqueous solubility, low bioavailability, and quick degradation and metabolism, curcumin was released using PLGA-PEG nanoparticles. Herein, the efficiency of pure curcumin and curcumin-loaded PLGA-PEG in MCF-7 human breast cancer cell lines was studied. (1)H NMR, FT-IR and SEM demonstrated PLGA-PEG structure and curcumin loaded on nanoparticles. Subsequently, the cytotoxic effects of free curcumin and curcumin-loaded PLGA-PEG were determined via an MTT assay. Our study confirmed that curcumin-loaded PLGA-PEG has more cytotoxic effects on the MCF-7 breast cancer cell line and could be exploited as a potential source for developing novel drugs against breast cancer.
dc.language.isoEnglish
dc.relation.ispartofArtificial cells, nanomedicine, and biotechnology
dc.subjectAntineoplastic Agents, Phytogenic
dc.subjectCell Survival
dc.subjectCurcumin
dc.subjectDrug Carriers
dc.subjectDrug Compounding
dc.subjectDrug Liberation
dc.subjectFemale
dc.subjectHumans
dc.subjectInhibitory Concentration 50
dc.subjectLactic Acid
dc.subjectMCF-7 Cells
dc.subjectNanoparticles
dc.subjectParticle Size
dc.subjectPolyethylene Glycols
dc.subjectPolyglycolic Acid
dc.titleA Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line.
dc.typearticle
dc.citation.volume44
dc.citation.issue1
dc.citation.spage423
dc.citation.epage30
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.3109/21691401.2014.955108


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record